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Abstract
We address the problem of information accessibility for patients concerned about,
pharmaceutical drug side effects and experiences. We create a new corpus of online
patieut-provided drug reviews and present our initial experiments on that corpus.
We detect biases in term distributions that show a statistically significant associa-
tion between a class of cholesterol-lowering drugs called statins, and a wide range
of alarming disorders, including depression, memory loss, and heart failure. We also
develop an initial language model for speech recognition in the medical domain, with
transcribed data on sample patient comments collected with Amazon Mechanical
Turk. Our findings show that patient-reported drug experiences have great potential
to empower consumers to make more informed decisions about medical drugs, and
our methods will be used to increase information accessibility for consumers.
Thesis Supervisor: Dr. Stephanie Seneff
Title: Senior Research Scientist
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Chapter 1
Introduction
The last few decades have witnessed a steady increase in drug prescriptions for the
treatment of biometric markers rather than overt physiological symptoms. Today,
people regularly take multiple drugs in order to normalize serum levels of biomarkers
such as cholesterol or glucose. Indeed. almost half of all Americans take prescription
drugs each month, which cost over $200 billion in the US in 2008 alone [301. However.
these drugs can often have debilitating and even life-threatening side effects. When
a person taking multiple drugs experiences a new symptom, it is not always clear
which, if any, of the drugs or drug combinations are responsible.
Before medical drugs and treatments can be approved in the US. clinical trials are
conducted to assess their safety and effectiveness. However, these costly trials have
been criticized because they are often designed and conducted by the pharmaceutical
company that has a large financial stake in the success of the drug. These trials are
often too short, and involve too few people to give conclusive results. A large study
recently conducted on the heart failure drug, nesiritude, invalidated the findings of
the smaller study that had led to the drug's approval [44]. Marcia Angell, who served
as editor-in-chief of the New England Journal of Medicine, also criticized the clinical
trials process, noting the conflicts of interest, the ease with which trials can be biased
to nearly ensure positive results, and prevalence of the suppression of negative trial
results [3].
Beyond clinical trials, regulatory agencies also monitor drug adverse reactions
through spontaneous reporting after the drug has come to market. In the United
States, the Food and Drug Administration (FDA) maintains a post-narketing surveil-
lance program called Medatcli, which allows healthcare professionals to report ad-
verse reactions of drugs. However. the difficulty of using these reporting systems and
their voluntary nature may contribute to an under-estimation of adverse drug reac-
tions [5,83]. It is difficult to accurately quantify the number of adverse reactions that
go unreported, but previous studies have found that voluntary reporting detects less
than 1% of adverse drug reactions [38]. In addition, patients and even clinicians may
not recognize that certain symuptoms are caused by the drug.
Increasingly, consumers are turning to online health websites to seek medical ad-
vice. Recently, a number of online communities have developed around sharing med-
ical experiences and expertise. These informal forums are rich and invaluable sources
of infornation on the effectiveness and side effects of drugs because they make it
possible to reach a wider audience, and suipplenent information available from drug
manufacturers and health professionals. For psychological reasons, patients are often
more comfortable sharing personal experiences in support, groups, with other partic-
ipants who are going through similar issues [15].
These health websites have the added benefit of closing the language gap between
clinical language and patient vocabulary, which can cause confusion and misunder-
standing. Studies have also shown that misspellings, misuse of words, and ambiguous
abbreviations can lead to poor information retrieval results [43, 52, 92].
Online health websites are addressing the issue of terminology mismatch., making
it possible to reach a wider audience. However they are subject to a different problem
of information overload. The trade-off of their accessibility is difficulty finding relevant
information for specific queries. The sheer volume of data and presence of noise masks
its true value.
Data mining and content summarization are well studied topics in research. es-
pecially in the restaurant and movie domains, where the opinion features of online
reviews are often overwhelmed by irrelevant commentary. By using a combination
of rule-based parsing and statistical analysis of the distribution and concurrence of
certain words and phrases, consumer connents can be consolidated to provide useful
sunnnarizations of individual restaurants with promising results [49].
Analogously, we can perform similar retrieval and sunmarization techniques in
the medical domain on patient anecdotes posted online, to address the dual problems
of insufficient clinical studies and mismatched terminology. Natural language analysis
of drug effectiveness and side effects could prove invaluable to patients who want to
learn more about the experience of taking certain drugs. However, the difficulty of
performing natural language analysis is increased in the medical domain because of
the highly domain-specific vocabulary, which also makes it interesting for natural
language research.
1.1 Vision
We propose an interactive online system that will answer questions about medical
drugs by consolidating patient-reported drug experiences and will automatically iden-
tify important and relevant information pertaining to drug effectiveness and side ef-
fects. The use of natural language understanding will allow more specific queries and
accessibility to individuals without medical training. Furthermore. in the absence of
relevant patient trials or consolidated and structured physician reports. the informna-
tion gathered by automatically processing patient reported symptoms may provide
invaluable insight on drug adverse reactions and effectiveness.
We envision an integrated system that encompasses a living database of patient-
reported anecdotes and supports both text and speech interaction modalities. The
system will be a valuable resource for patients who want to learn about and share
experiences on the effectiveness and side effects of medical drugs. Users will not
only be able to ask questions about drugs or symptoms, but also submit their own
comments by typing or speaking about their experiences taking certain drugs. The
database will also incorporate information mined from online patient discussions of
drugs and publicly available medical data sets, such as the FDA's Adverse Events
Report System, which contains reports from MedWatch. As more people use the
system, the database will be augmented with these new entries and thus deliver more
relevant results to new queries.
In response to user queries, relevant comments from the database will be returned
that may provide the answers the user seeks. To avoid overloading users with too
many comments. we will use automatic summarization techniques to highlight the
key points relevant to the user query. Statistical analysis may also be performed to
answer questions about population statistics, such as the correlation between observed
symptoms and certain drugs.
1.2 Contributions
This thesis describes our preliminary experiments in building an interactive medical
drug resource for patients. As a preliminary study in this area. we tackle a number
of common tasks including spelling correction, tokenization. and term identification.
We also explore the degree to which statistical methods such as co-occurrence mea-
sures, linear classifiers, and topic models can be used to extract summary information
derived from biases in word distributions, and to subsequently detect associations be-
tween particular drugs or drug classes and specific symnptons.
The key contributions of this research are:
1. We create a large corpus of over 100.000 patieit-provided medical drug reviews
and comments.
2. We apply statistical techniques to identify side effects and other terms associated
with a specific drug class.
3. We apply topic modeling methods to discover drug side effects and side effect
classes.
4. We develop an initial speech recognition system to support spoken queries in
the medical domain.
1.3 Thesis Overview
The thesis is organized as follows. First. we provide an overview of related work in
natural language processing in the medical domain. We then describe the data col-
lected on medical drug reviews and comments. In chapter 4, we discuss the findings
from automatic side effect discovery experiments with a focus on cholesterol-lowering
drugs, especially statins. We present results from speech recognition experiments
conducted on spoken question data collected from Amazon Mechanical Turk in chap-
ter 5. We discuss additional experiments in review classification and topic modeling.
followed by our conclusions in chapter 7.
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Chapter 2
Related Work
This thesis builds on a number of areas of previous work, from general tasks such
as word sense disambiguation, syntactic parsing, and topic detection. to the domain
specific applications of clinical decision making, medical dialogue systems, and diag-
nosis. With the adoption of electronic health records and increased availability of
clinical data in textual forn [55] it is becoming increasingly feasible to apply NLP
techniques to the medical doimain. Natural language processing methods have already
been used to supplement hcalth provider education, provide more personalized med-
ical care, and assist in a patient's behavioral compliance, which can greatly reduce
the billions of dollars spent each year on health care by encouraging healthier life
styles [23]. In this chapter, we will give an overview of term identification methods.
which are crucial to many NLP tasks. We also present a survey of applications in the
medical domain.
2.1 Term Identification
The development of natural language systems in specialized domains often begins
with term identification, an important subtask of information extraction with appli-
cations in automatic indexing, language generation, and machine translation. The
term identification task can be subdivided into three main steps, (1) term recognition.
(2) term classification, and (3) term mapping. As an example, consider the sentence
"Lipitor caused muscle pain." In the recognition step. we would detect two terms of
interest (Lip itor and muscle pain). We would then classify the terms as a drug name
and adverse reaction, respectively. Finally, we would map these terms to concepts in
a medical lexicon, such as the UMLS Metathesaurus, which is described in detail in
section 2.1.1.
Proper treatment of the term identification task may involve parsing techniques
that consider contextual information, statistical methods that use measures such as
frequency or term frequency inverse document frequency (tf-idf), and lexicon based
methods that compare terms against words in a given knowledge base. Term classi-
fication is often performed with classifiers using semantic, contextual. and syntactic
features, for example, Chowdhury ct al. 's work on identifying medical terms, including
diseases [10], Settle's study of gene and protein names [69] and Aramaki's experiments
on extracting adverse effects from clinical records [4].
2.1.1 Medical Knowledge Resources
The US National Library of Medicine (NLM) has created a set of biomedical lex-
ica and tools known collectively as the Unified Medical Language System (UMLS).
First developed in 1986. it is updated quarterly and is used extensively in biomedical
NLP research. Resources within the UMLS include the Metathesaurus 1, composed
of over 1 million biomedical concepts, the Semantic Network (which provides semnan-
tic links among categories such as organisms. anatomical structures, and chemical
compounds), and the SPECIALIST Lexicon of both common English and biomedical
terms. with syntactic information.
Within the Metathesaurus, we find many specialized vocabularies including RxNorm,
a "standardized nomenclature for clinical drugs and drug delivery devices" [50], the
World Health Organization (WHO) Adverse Drug Reaction Terminology, and Med-
linePlus Health Topics, among 50 others2 . Concepts found in the Metathesaurus can
'http: //www.nlm.nih.gov/pubs/factsheets/umlsmeta.html
2http: //www .nlm.nih. gov/research/umls/knowledgesources/metathesaurus/release/
sourcevocabularies.html
be mapped to semantic types in the Semantic Network.
Applications
An iniportant application of term extraction is the identification of adverse reaction
terms. . Penz et al. [60] studied text records of surgical operations in the Veterans
Administration database to identify the effect of central venous catheter placements
on adverse reactions. Using phrase matching and parsing techniques, they were able
to identify adverse reactions with 0.80 specificity and 0.72 sensitivity. Melton and
Hripcsak [54] achieved much higher specificity (0.99) at the cost of sensitivity (0.28).
Despite the availability of manually annotated resources such as UMLS, it remains
difficult to map terms found in text to concepts in these medical lexica. Histori-
cally. dictionary look-up methods in the medical domain have exhibited poor match-
ing [26,35]. The NLM has developed a tool called MetaMap Transfer (MMTx), which
automatically maps biomedical documents to terms in the UMLS Metathesaurus us-
ing text parsing, linguistic filtering, variant generation, and finally matching to con-
cepts in the Metathesaurus [36]. However, Divita [18] found that MetaMap Transfer
had only a 53% success rate at matching terms in free text to concepts in UMLS.
Settles's work also suggested that, the use of semantic lexica may be of questionable
benefit compared to text-based features for entity recognition purposes [69]. The
term recognition problem is especially pronounced in the medical domain because of
the fast-evolving vocabulary and ambiguity or polysemny of terms.
2.1.2 Statistical Approaches
Statistical and machine learning techniques may prove more successful at term recog-
nition than approaches that rely on accurately mapping free text to controlled vo-
cabularies, especially with the availability of large datasets. For example, Kazama et
al. [41] used multi-class support vector machines (SVMs) to learn boundary features
of terms in the GENIA corpus3 . Another study employed Hidden Markov Models
3http://www-tsujii.is.s.u-tokyo.ac.jp/~genia/topics/Corpus/
(HMMs) with orthographic features to discover gene names [131.
With the high density of medical terms in text. we can also use probabilistic
collocation extraction methods to identify terms of interest. A number of measures of
association have been used in previous research, including simple frequency, pointwise
mutual information [11], selectional association [63], log-likelihood [20]. symmetric
conditional probability [71]. and set association measures such as the Dice [17] and
Jaccard [371 indices. Many of these measures are defined in more detail in section 4.3,
where they are used to detect biases in word distributions.
2.2 Medical Applications
Using tools such as the UMLS, researchers have studied medical text for a wide range
of purposes. Weeber et al. found new applications for medical drugs through textual
analysis of PubMed articles. They argued that researchers should consider textual
databases as an additional source of knowledge. Reeve et al. used various associa-
tion measures to determine concept saliency in biomedical texts for extractive text
sinumarization. Plaza et al. [61] applied a graph-based approach to map terms in
biomedical documents to concepts found in UMLS, also for summarization purposes.
These studies, based on documents containing many technical biomedical terms, ben-
efit from the use of the UMLS Metathesaurus for mapping terms to medical concepts.
Additional applications include medical dialogue systems and biosurveillance, which
are described below.
2.2.1 Dialogue Systems
Personalized medical systems often implement a dialogue system that aims to simu-
late or supplement the expertise of health care providers [46]. Conversational systems
provide a more natural interface for users, and have been applied with limited success
to many domains. These systems face the challenges of adapting to unconstrained
interaction with patients, and generalization beyond the training data. Speech recog-
nition and language modeling are also challenges faced in this and other constrained
domains, such as weather or flight booking [27. 68]. Furthermore, the usefulness of
a question answering system for patients depends not only on its ability to return
relevant answers, but on its ability to present these answers in a manner easily ac-
cessible to viewers. Improvements in natural language understanding and generation
are integral parts of such systems, which would ideally be able to respond to the kind
of unconstrained questions patients might direct to their physicians or pharmacists.
These challenges have been tackled by health dialogue systems; a notable example
is Chester, a personal medication advisor prototype developed at the University of
Rochester [2]. Chester was designed with the aim of alleviating the increasing bur-
den placed on patients to manage their health and medical treatments, especially in
light of the life-threatening complications that may arise from nissed pills or drug
interactions. Comnunicating with patients using natural language dialogue makes
Chester most accessible to people familiar with the behavior of expert health care
providers, and requires nminimnal training to use. More specialized spoken medical
dialogue systems have also been developed, such as Rojas-Barahona et, al.'s HomcNL
system, which engages in conversation with and offers suggestions to patients who
have hypertension [64].
Speech Recognition
An integral part of dialogue systems is speech recognition, which is the process of
turning a speech signal into a sequence of recognized words through appropriate rep-
resentation and the application of acoustic, lexical, and language models. At the
acoustic level, a live recognition systemin must be able to adapt to variations in micro-
phone placements or sound quality. In natural language understanding, difficulties
arise from ambiguities in both syntax and word meanings. A given sentence can be
produced from multiple parse trees. and the same word has different meanings in
different contexts. These problems are compounded with imperfect pronunciation,
spelling and punctuation, as is often the case with informal comments posted on-
line. To accurately parse sentences, we must use a combination of semantic rules and
probabilistic models. Statistical language models have been found to be very effective
at improving speech recognition without needing complex syntactic rules, by giving
more probability to frequently observed word sequences.
However, while acoustic and lexical models are often portable across domains.,
language models must be more carefully adapted for domain-specific use to achieve
higher performance in recognition systems. Adaptation of general language models
or cross domain training have been researched, with specific techniques including the
use of domain specific corpora [661, model interpolation [88], or training on artificial
corpora generated automatically from templates [42].
Of note in such previous research are the steps taken to address the domain-
specific data sparsity issues, and the lack of pronunciation data or mispronunciation
by users of the system. These health connnunication systems have also tackled the
problem of knowledge representation for the complex relations between drugs, drug
effects, and side effects in teris of time and severity.
2.2.2 Health Surveillance
The increased accessibility of public health information through the wcb has also
driven research in text mining for health surveillance. Many Web-based surveillance
systems have been developed that focus on event-based monitoring, including the
Global Public Health Intelligence Network (GPHIN) [58], HealthMap [25] and Bio-
Caster [12], which gather data from sources such as news reports, official reports, and
World Health Organization (WHO) alerts.
BioCaster's system can be decomposed into three major subtasks. namely topic
classification, named entity recognition. and event extraction. Document classifica-
tion was performed using a naive Bayes algorithm, which achieved 94.8% accuracy,
and named entity recognition achieved an F-score of 77.0% using a support vector
machine. The task faced the challenge of high data volume. the fast response time
needed, and out-of-vocabulary terms. It was developed by researchers in Japan, Viet-
nam. and Thailand, and focuses on Asia-Pacific languages.
These surveillance systems can provide more comprehensive and timely informa-
tion. For example, GPHIN detected the 2002 outbreak of Severe Acute Respiratory
Syndrome (SARS) through news media analysis three months before official WHO re-
ports [21]. HealthMap. developed in the Harvard-MIT Division of Health Sciences &
Technology, mines imanv online text sources and integrates data from location-aware
devices to create a "global disease alert map." It was a useful tool to visualize and
track the spread swine flu during the 2009 flu pandemic.
Pharmacovigilance
A special category of health surveillance is pharinacovigilance, or the detection of
adverse drug reactions. Postmarketing pharinacovigilance is an area that benefits
greatly from NLP methods, as electronic health reports can be analyzed to detect
new drug side effects. One of the earliest studies of this kind involved the manual
review of patient-reported text conprised of emails sent to the BBC and messages on
an online discussion site. Medwara et al. [53] found that the user reports showed a
correlation between the antidepressant, paroxetine, and severe withdrawal synmptoms
and suicide. This study lends support for the use of patient-provided text for detecting
drug and drug adverse reaction relationships.
A more recent study conducted on a wider range of drugs show even miore promise
that user connents contain information that can be used in pharmnacovigilance. Lea-
man et al. [48] studied user comments posted on the DailyStrength 4 health site and
found that the incidence of patient-reported side effects were in line with documented
incidence from the FDA online drug library. They compared patient counents
against a lexicon of medical terms found in the FDA's COSTART vocabulary set.
In another study, Cable [8] manually examined 351 patient-reported comments
on statin adverse reactions and found that not only all patients experienced side
effects, but more than 60% reported that they discontinued the drug because of the
severity of the side effects. While one may question the validity of using self-reported
anecdotes rather than controlled studies, in aggregate, anecdotes can provide useful
information, as Cable demonstrates. Furthermore. his findings are backed by research
literature, described in more detail in section 4.1.1.
4http://www.dailystrength.org
2.3 Summary
Prior work has focused in part on improving term recognition, one of the largest
bottlenecks to medical text mining. The increased availability of electronic health
information and the development of medical lexica have enabled a number of projects
in personalized medical care and health surveillance. However, to improve the ac-
cessibility of health information, we still face the challenge of a large language gap
between consumers and clinical documents. and the overwhelming volume of text
now available online. In our research, we take a contrasting approach to previous
methods, placing emphasis on statistical and parsing techniques, instead of relying
on manually created knowledge sources such as the UMLS.
Chapter 3
Data
A large part of the drug reports system is the large database of patient- provided drug
reviews and drug experience comments collected from various health-related sites.
This corpus of comments will be referred to as the DrugReports corpus hereafter. In
this chapter, we describe our data collection process and give an overview of the data
collected.
Because of the constant addition of new cornents posted to online health sites,
we designed a comment collection system that would regularly update the database
of comments while being (1) extensible to new sites, (2) easy to configure for new
drug classes, and (3) minimal in bandwidth consumption.
3.1 Data Collection
For each web site. data collection is performed with the following steps:
1. Given a search term, URLs of relevant pages are collected.
2. URLs for all search terms are collected and a unique set of URLs are recorded.
3. Web pages corresponding to the URLs are downloaded and cached. Cached
web pages which are less than a week old are skipped, to reduce unnecessary
network bandwidth usage.
4. Comments are extracted from the HTML pages. along with supplementary in-
formation such as author and time posted.
5. The comments are loaded into the database following the schema in Figure 3-1.
3.1.1 Data Sources
Each web site follows a different format, so we iniplemented site-specific scrapers that
collect all comments given the name of a drug. Drug reviews were harvested from
five sites dedicated to (or containing sections dedicated to) reviews of pharmaceu-
tical drugs: (1) WebMD1 . (2)Askapatient (3) Medications3 , (4) iGuard4 , and (5)
DrugLib5 . Many of these sites were established almost ten years ago (WebMD and
Askapatient). while some were established as recently as 2007 (iGuard). WebMD is
one of the largest online health portals. with over 17 million unique monthly visitors
in 2007.
These sites each allow users to post reviews of specific drugs, providing comments
labeled with the drug name. Some sites encourage users to specify supplementary
information such as gender, age. side effects and ratings, similar to product and
restaurant review sites. Table 3.1 presents a numerical overview of the collected data
with contributions from each site.
Site Review count Contribution
WebMD 4124 34%
Askapatient 3960 33%
Medications 3055 25%
iGuard 897 7%
DrugLib 82 1%
Table 3.1: Sources of data and number of reviews of cholesterol lowering drugs.
In addition, many health websites allow users to post general comments in forums,
ihttp: //www.webmd. com/
2http ://www. askapatient . com/
3http://www.medications.com/
4http://www.iguard.com/
5http: //www. druglib. com/
Site
title :string
url:strino
Page
title :string
url :string
date accessed :datetiie
body :text
Conunent
author :stiing
body :text
url :string
posted at :datetime
side effects :text
pros :text
cons :text
rating :integer
max rating :integer
sideeffectsrating :integer
effectiveness rating :integer
reason :string
author info :text
sex :string
age :sting
duration :string
dosage :string
other medications :text
weight :integer
other conditions :text
Figure 3-1: Database schema for storing patient comments.
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or as responses to articles posted by the site's editors. These sites include: (1) WebMD
Blog 6, (2) People's Pharmacy 7, (3) Healing Well?, and (4) Spacedoc9 . Most of these
are general health web sites with the exception of Spacedoc.net, which has forums
focused on cholesterol related drugs. Unlike the sites dedicated to drug reviews, these
sites tend to contain comments that are less relevant to specific drugs.
3.1.2 Data Coverage
Because many substances are marketed under country-specific brand names, we col-
lected reviews for all brand names popular in English speaking countries, as well as the
generic names. For example, simvastatin is marketed as Zocor in the US and Lipex in
Australia. The drug classes covered are separately configured in a file that contains
the names of all drugs and the hierarchy. The drug hierarchy is adapted from the
Anatomical Therapeutic Chemical (ATC) Classification System. which is managed
by the WHO Collaborating Centre for Drug Statistics Methodology, and organizes
drugs based on their therapeutic use and chemical characteristics. A portion of the
drug hierarchy we use can be found in Appendix A.
For the scope of this thesis, we focused on cholesterol-lowering drugs, which rank
among the most prescribed pharmaceuticals ever. Their prevalence allows for a large
quantity of patient-reported data. Furthermore, preliminary examination of online
medicine and patient forums shows a large number of responses which include re-
ported drug side effects such as muscle weakness and memory loss [1]. We collected a
total of over 12,000 reviews about drugs falling under ATC class C1O, which includes
all lipid modifying drugs. These drugs may be referred to interchangeably as choles-
terol lowering drugs. Figure 3-2 presents an overview of the size and distribution of
comments over different classes of cholesterol lowering drugs.
6http://blogs.webmd.com/
'http://www.peoplespharmacy.com/
8http://www.healingwell.com/
9http://www.spacedoc.net/
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Figure 3-2: Distribution of comments in cholesterol lowering drug class. Numeric
values are total nunber of reviews in each class.
3.2 Example Comments
The comments collected often consist of very detailed descriptions of their drug use
and symptom progression. For example. one user who posted on People's Pharmacy
shared the following:
M\y father was perscribed lipitor in March of 2004, subsequently he de-
veloped muscle weakness and numbing and stopped taking it. The weak-
ness did not go away, lie got progressively weaker and was recommended
to see a neurologist. In September of 2004 the neurologist diagnosed him
with ALS ... He died in March of 2005, onei month after his birthday and
less than one year after taking lipitor.
The above is quite typical of conments posted online, whether on forums or in
response to articles relating to statins. They are written in natural language. with a
variety of sentence structures, misspellings, or grammar mistakes. Acronyms such as
"ALS" (which stands for amnyotrophic lateral sclerosis) abound. At the same time,
these anecdotes allow users to share more relevant information than can be anticipated
by structured forms.
3.3 Spelling Correction
We performed spelling correction on the entire corpus of user comments as a prepro-
cessing step for all NLP tasks, with the goal of correcting words of medical interest
that were misspelled frequently by many users. Collected data were first tokenized
and case-normalized, and stop words were removed, following a commonly used stop-
word list [24]. Comments were then processed with automatic spelling correction as
described below.
We began with a unique list of all unigrams composed only of the characters a-z.
These 20,601 words were first sorted by likelihood of being misspelled based on the
log ratio of unigram probabilities between the DrugReports corpus and the Google
u-gram corpus 0 . The Google i-gram corpus is a collection of unigramns up to 5-grains
with counts collected from public Web pages. and thus contains a wider vocabulary
than conventional corpora.
For a given word w. we can define c(w) as the count of w in the Google n-grain
corpus, and Cd(w) as the count in the DrugReports corpus. Words that have a high
ratio of unigram probabilities are either more likely to be misspelled, because they
have low or zero cg(w), or more likely to be medically relevant with a higher Cd(w).
Upon manual inspection, we set a threshold cutoff for the unigram probability
ratio at 0.20, resulting in a list of 17,199 unique words. We then further pruned
the list of potentially misspelled words by eliminating those that satisfied any of the
following conditions:
1. cg (w) > 1.000,000
2. Cd(W) > 120
3. w appears in comments from only one site.
4. w appears in an external corpus that is unlikely to contain misspellings.
'ohttp: //googleresearch .blogspot . com/2006/08/all-our-n-gram-are-belong-to-you.
html
The count thresholds were manually chosen to eliminate all frequent words that
were not misspellings. Words that appeared only on one website (of the nine sites
scraped) were removed because they are inherently uninteresting; often these were
usernamnes or repeating character sequences. We also removed words that appeared
in a set of commonly used external corpora' - the Brown corpus, Project Gutenberg
Selections, the Genesis corpus, the Australian Broadcasting Commission corpus., the
Reuters corpus, the Wordlist lexicon. and health articles and documents from Google
Health. NIH, WebMD, Wikipedia. and iGuard. These published texts were chosen
because they are less likely to contain misspellings.
The filtered list contained 3,025 candidate misspelled words. Proposed corrections
were automatically generated for these words based on near-miss match to words
that appeared at least 8 times in the DrugReports corpus (single-letter substitution.
insertion, deletion; two letters inverted). In the case of multiple matches. the word
with the highest unigram was chosen. Implausible corrections were discarded after
manual inspection, resulting in a final count, of 2,678 spelling correction rules. These
were then applied to the entire corpus.
11http: //code .google . com/p/nltk/wiki/Corpora
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Chapter 4
Automatic Discovery of Side
Effects: Focus on
Cholesterol-Lowering Drugs
We explore the use of the corpus of patient-provided drug reviews in discovering drug
adverse reactions. Patient-provided medical drug experiences can supplement drug
adverse reaction findings and address the issue of the large language gap between
patients and technical medical documents [93].
Previous work has been conducted to extract drug side effects from text. for
example., mining drug package inserts to link drugs to side effects [45] or detecting
infectious disease outbreaks by monitoring online news reports [12]. These studies
have generally been concerned with technical text. Self-reported data poses a greater
NLP challenge because of misspellings. ungramniaticality. and shorthand. While
little extensive research has been conducted on patient-reported comments, we canl
compare with electronic health records, written unedited by clinicians to document
patient conditions, that have as high as 10% incidence of misspellings [65]. Studies
have also raised the problem of mapping terms in consumer health texts to concepts
in UMLS; Divita [18] found that MetaMap Transfer had only a 53% success rate at
matching terms in free text to concepts in UMLS. It is possible that patient-provided
comments are even more difficult to analyze because, without any medical training.,
non-clinicians are more likely to misspell and misuse words, and employ more creative
use of language.
Leaman et al. [48) attempt to account for unexpected vocabulary by using the
UMLS lexicon. further supplemented with a few colloquial terms, to detect adverse
reactions from self-reported online posts. One of their observations was that the fre-
quency of side effects in user comments was highly correlated with their documented
frequency as provided by the FDA. Their study is the only one that we are aware of
that performs textual analysis of online patient-provided comments.
In this chapter, we use several popular statistical NLP techniques to detect bi-
ases in word distributions when comparing reviews of statin drugs with reviews of
other cholesterol-lowering drugs. We focus on these drugs because they are widely
prescribed and have diverse side effects. We will begin with a review of the research lit-
erature reflecting known or suspected side effects associated with cholesterol-lowering
drugs. We will then describe the set of statistical NLP techniques we used to de-
tect likely associations between particular drug classes and particular health issues.
We verify that many of our extracted associations align with observations from the
literature.
4.1 Side Effects of Cholesterol-lowering Drugs: Brief
Literature Review
In this section, we briefly review some of the literature on associations between
cholesterol-lowering drugs and certain side effects. We will focus our discussion on
the important class of HMG coenzyme A reductase inhibitors (statins) which have
become increasingly prescribed as very effective agents to normalize serum cholesterol
levels. The most popular of these, atorvastatin, marketed under the trade name, Lip-
itor, has been the highest revenue branded pharmaceutical for the past 6 years'. The
official Lipitor web site lists as potential side effects mainly muscle pain and weakness
and digestive problems. However. several practitioners and researchers have identified
1http://www.drugs.com/top200.html
suspected side effects in other more alarming areas, such as heart failure, cognition
and memory problems, and even severe neurological diseases such as Parkinson's
disease and ALS (Lou Gehrig's disease).
4.1.1 Statin Drugs
It is widely acknowledged that statin drugs cause muscle pain, weakness, and dam-
age [32, 56], likely due in part to their interference with the synthesis of the potent
antioxidant Coenzyme Q10 (CoQ10) [47]. CoQ1O plays an essential role in nitochon-
drial function to produce energy. Congestive heart failure is a condition in which the
heart can no longer pump enough blood to the rest of the body, essentially because it
is too weak. Because the heart is a muscle, it is plausible that heart muscle weakness
could arise from long-term statin usage. Indeed, atorvastatin has been shown to im-
pair ventricular diastolic heart performance [72], and low cholesterol levels were also
found to be associated with greater 12-month mortality risk in patients with chronic
heart failure [62]. Furthermore. CoQ10 suppleimenitation has been shown to improve
cardiac function [57,86].
The research literature provides plausible biological explanations for a possible
association between statin drugs and neuropathy [73, 94]. A recent evidence-based
article by Cable [8] found that statin drug users bad a high incidence of neurological
disorders, especially neuropathy, parasthesia, and neuralgia, and appeared to be at
higher risk to the debilitating neurological diseases, ALS and Parkinson's disease.
His study was based on careful manual labeling of a set of self-reported accounts
from 351 patients. A mechanism for such damage could involve interference with the
ability of oligodendrocytes, specialized glial cells in the nervous system, to supply
sufficient cholesterol to the myelin sheath surrounding nerve axons. Higher serum
cholesterol levels have been correlated with prolonged survival in patients diagnosed
with ALS [19]. Sim et al. [74] showed that statin drugs lead to recruitment of large
numbers of glial progenitor cells to mature into oligodendrocytes. likely because of a
reduced efficiency of the pre-existing oligodendrocytes. Genetically-engineered mice
with defective oligodendrocytes exhibit visible pathologies in the myelin sheath which
manifest as muscle twitches and tremors [67].
Cholesterol depletion in the brain would be expected to lead to pathologies in
neuron signal transport, due not only to defective myelin sheath but also to interfer-
ence with signal transport across synapses [81]. Cognitive impairment, memory loss,
mental confusion. and depression were significantly present in Cable's patient popula-
tion [8]. Wagstaff et al. [84] conducted a survey of cognitive dysfunction from AERS
data. and found evidence of both short-term memory loss and amnesia associated with
statin usage. Golomnb et al. [29] conducted a study to evaluate evidence of statin-
induced cognitive, mood or behavioral changes in patients. She concluded with a plea
for studies that "more clearly establish the impact of hydrophilic and lipophilic statins
on cognition, aggression, and serotonin." It is anticipated that lipophilic statins would
be more likely to cross the blood-brain barrier and therefore induce more neurological
problems.
Wainwright ct al. [85] provide compelling arguments for the diverse side effects
of statins, and attribute them mainly to cholesterol depletion in cell membranes.
Another study by Goldstein and Mascitelli [28] found that in cardiovascular patients,
those taking statins are at a 9% higher risk of developing diabetes compared to those
on a placebo. Statins have also been linked to decreased serotonin levels [14], and
thus depression. as well as decreased testosterone [16], which may affect male sexual
response.
4.1.2 Non-Statin Cholesterol-Lowering Drugs
The four main alternatives to statin drugs for improving lipid profile are fibrates, bile
acid sequestrants (such as Questran and Welehol), nicotinic acid (niacin) derivatives
and ezetimibe. which interferes with the absorption of cholesterol through the gut.
The main side effect associated with niacin is the so-called "niacin flush." A biological
explanation for its cause is provided in Hanson et al.'s research [33]. Patients taking
ezetimibe can experience abdominal or back pain, diarrhea, joint pain. and sinusitis.
Rare side effects include coughing, fatigue. sore throat, sexual dysfunction and viral
infection2 . A popular drug combination is Vytorin, which contains simvastatin (a
statin) combined with Zetia. Possible side effects are rash, pancreatic inflammation.
nausea, headache, dizziness. gallstones., gallbladder inflammation. and swelling of the
face. lips, tongue, and throat.
4.2 Data
We use data from drugs affecting the cardiovascular system, specifically those falling
under ATC class C1O, which includes all lipid modifying drugs. Statin drugs and
other cholesterol-lowering drugs belong in this class. In addition, we collected data
on drugs used to treat hypertension (ATC class C09), which serves as a fair corpus
for comparison with cholesterol-lowering drugs, as it also affects the cardiovascular
system.
The sites that these reviews were drawn from include all sites that contain labeled
drug reviews, as seen in Table 3.1.
4.3 Methods
Our goal was to assess the usefulness of patient-reported free-text drug reviews in
determining the side effects and areas of concern associated with certain drugs. We
compared two mutually exclusive drug classes at one time, for example, statin drugs
and other non-statin cholesterol lowering drugs. Such a comparison should highlight
the side effects more associated with statin drugs than other drugs used for the same
purpose of improving lipid profile. By comparing drugs within the same class, we can
highlight features that distinguish two drugs that are used for the same purpose, thus
controlling for patient preconditions.
We map our problem onto the general task of measuring association between two
discrete random variables, X and Y. In our case, P(X = x) is the probability of a
term x being contained in any document. P(Y = y) is the proportion of documents
2http://www.zetia.com/ezetimibe/zetia/consumer/index.jsp
in a given class (e.g. statin). P(x, y) is the probability that any given document is
both in class y and contains term x. Terms can be n-grams with n < 5.
Association measures have been used extensively for collocation identification [11].
sentence boundary detection [91] and word sense disambiguation purposes [63]. From
an information-theoretic perspective, our problem maps well to the approach taken by
[63] for word sense disambiguation by characterizing the co-occurrence of predicates
with conceptual classes. We define the measures we use below, along with brief
explanations of their adaptation to our problem.
4.3.1 Log Likelihood Statistic
Dunning's likelihood ratio test [20] is a statistical tool used to compare the homo-
geneity of two independent binomial distributions. It follows the V2 distribution with
one degree of freedom, but unlike the y2 test. has the benefit of being robust to
non-normal and low-volume data. We derive the likelihood ratio below.
Suppose a document has a probability p of containing the term x and we observe
k docuiments of n total containing at least one instance of x. We can express the
likelihood of this observation as the result of a repeated Bernoulli trial:
With the log likelihood ratio (LLR), we compare the maxinumi values of the
likelihoods of the null hypothesis (Ho) of there being a single probability p that
explains both classes with the likelihood of two classes having different probabilities
pi and P2 of containing the term x (H 1 ). The likelihoods of these two hypotheses are
expressed in Equations 4.2 and 4.3.
Ho(x) = pk1+k2 (I _ PnI-k1 +n2-k 2 Qn,) (n2) (4.2)
H1 (x) = p1,(1 - 91)"1-k niP2(1 - P2) n2-k2 n)(4.3)
The log likelihood ratio is then defined as:
LLR(x) = E ki log A + (ni - ki) log (4.4)
iC{1,2}
where p and p- are the values that maximize the likelihoods, i.e.:
k1 + k2 ki
ni + n2 ni
To avoid division by zero and to compensate for sparse data, we used add-one smooth-
ing scaled by the data set size.
Because the log likelihood statistic only tells us how unlikely it is that the two
classes of documents have the same probability of containing the term x. we further
define here a class preference measure. obtained by splitting the log likelihood ratio
into two terms. The first term, defined in Equation 4.5, collects the terms associated
with class 1. A symmetrical calculation can be made for class 2. The difference
between these two terms is a measure of class preference.
A 1 = k1 log - + (n 2 - k2 ) log P2 (4.5)
P -P
4.3.2 Pointwise Mutual Information
Commonly used in information theory, pointwise mutual information allows us to
quantify the association between the two discrete random variables associated with
outcomes x and y:
P(x. y)PMJI(. y) = log P(x'PY) (4.6)
Furthermore, the ratio between PAJI(x, yi) and PMI(x, Y2) (i.e. the difference)
can tell us which words are more closely associated with one class than another, much
as the semantic orientation of words was calculated by Turney [82].
4.3.3 Set Operations
We also include two set operation based measures - Dice and Jaccard coefficients. Let
D, and Dy be two sets of documents containing the term x and relating to drug class
y, respectively. Dice's coefficient calculates their similarity as follows:
Dice (x, y) =- + " (4.7)
Dx|+ I~u|
The Jaccard coefficient is defined as:
Jaccard(x, y) = (4.8)|Dx U Dv|
The preference of a term x for class y1 over class Y2 can be found as a ratio between
Dice(x, yi) and Dice(x, y2). or the Jaccard coefficients.
4.4 Results
Below, we will highlight some of the most interesting results that emerge from com-
parisons of various data sets.
4.4.1 Cholesterol-lowering vs Blood-pressure-lowering Drugs
Terms related to muscle pain and weakness and memory problems were far more
common for the cholesterol-lowering drugs, as well as more unexpected words like
arthritis, joint pain and spasms. Blood pressure drugs had a much more frequent
appearance of words related to the cough associated with ACE inhibitors, such as
chronic cough, hacking. throat, etc. Sex drive and dizziness were also prominent for
blood pressure drugs. Selected terms can be found in Table 4.1.
Table 4.1: Selected words and phrases that distributed differently over cholesterol-
lowering drug reviews and renin-angiotensin drug reviews. The log-likelihood ratio
(LLR) and p-value are provided. ki: cholesterol-lowering drugs. k2 : renin-angiotensin
drugs. *Values are essentially 0 (< lE - 300).
4.4.2 Statins vs Non-statins
Within the cholesterol-lowering drug class, we compared the set of 7.971 statin reviews
with 3.549 reviews for non-statin cholesterol-lowering drugs. Table 4.2 shows the top
20 terms associated with statins. ranked by each of the association measures discussed
in Section 4.3. Table 4.3 presents the terms for non-statin cholesterol-lowering drugs.
The rankings from these measures exhibit high correlation with one another.
Gastrointestinal issues and rashes are common to patients taking other cholesterol-
lowering drugs. These findings are in line with the expected side effects of niacin
derivatives, fibrates, and ezetniibe, which dominate the non-statin reviews.
The drug names can be used as a reference against which to compare the other
terms. The fact that pain appears between lipitor and zocor shows that pain is
strongly associated with statins in the drug reviews. The list is highly dominated by
unigrams because of data sparsity. Methods to better treat low count data may be
an area of further investigation.
Table 4.4 highlights a few terms that are highly associated with either the statin
or the non-statin class, ranked by the log likelihood ratio expressed in Equation 4.4.
The class preference measure determines whether the term was more associated with
Term ki k2  LLR p-value
cholesterol 3108 91 3644.78 0*
arthritis 325 86 128.39 9.22E-30
spasms 212 56 83.42 6.63E-20
joint pain 560 293 63.78 1.39E-15
cough 66 2583 3644.78 0*
blood pressure 292 2556 2573.64 0*
throat 160 745 485.9 1.11E-107
hacking 3 219 299.32 4.63E-67
dizziness 376 821 226.14 4.14E-51
chronic cough 3 66 77.33 1.45E-18
sex drive 124 181 17.07 3.60E-05
Rank PMI Ratio LL Ratio Dice Jaccard
1 lipitor lipitor lipitor lipitor
2 short term memory loss pain zocor pain
3 pain zocor simvastatin zocor
4 short term memory simvastatin pain muscle
5 zocor muscle crestor simvastatin
6 muscle crestor memory crestor
7 tern memory loss memory muscle cholesterol
8 simvastatin loss loss loss
9 crestor memory loss walk memory
10 memory loss walk cholesterol legs
11 muscle pain cholesterol memory loss walk
12 term memory pravachol legs symptoms
13 cholesterol legs symptoms taking
14 memory pains pains drug
15 loss left left pains
16 symptoms symptoms feet muscle pain
17 legs feet statin left
18 walk walking muscle pain feet
19 pains term memory muscles muscles
20 left short term memory walking statin
Table 4.2: Twenty ternis with highest class preference for statin drug reviews.
Rank PMI Ratio LL Ratio j Dice J Jaccard
1 niaspan
2 flushing
3 tricor
4 zetia
5 itching
6 aspirin
7 welchol
8 low fat snack
9 taking tricor
10 niaspan er
11 niacin
12 burning
13 triglycerides
14 fire
15 sunburn
16 baby aspirin
17 flush
18 snack
19 chronic diarrhea
20 iight
niaspan
flushing
tricor
aspirin
itching
zetia
welchol
fire
niacin
sunburn
snack
triglycerides
flush.
burning
niaspan er
benadryl
trilipix
gallbladder
bedtime
applesauce
niaspan
flushing
tricor
aspirin
itching
zetia
welchol
fire
niacin
triglycerides
burning
flush
taking tricor
sunburn
snack
bedtime
skin
reaction
diarrhea.
woke
niaspan
flushing
tricor
itching
zetia
aspirin
welchol
fire
triglycecrides
niacin
burning
flush
skin
bedtime
reaction
sunburn
diarrhea
woke
snack
bathroom
Table 4.3: Terms with high class preference for non-statin drug reviews.
Table 4.4: Selected words and phrases that distributed differently over statin and
non-statin cholesterol lowering drug classes. The log-likelihood ratio (LLR) and p-
value are provided. ki and k2 : number of statin and non-statin reviews containing
the term, respectively. The upper set are far more common in statin drug reviews,
whereas the lower set are more frequent in non-statin reviews.
statins or non-statin cholesterol lowering drugs. Many memory and muscle-related is-
sues are more apparent with patients taking statins. The highly significant results for
diabetes are in line with recent concern about the possibility that statins may increase
risk to diabetes [31]. Depression also exhibits a significant bias towards statins. This
effect may be attributable to their known interference with serotonin receptors [70].
Heart failure was also much more conmion in the statin drug branch, consistent with
the findings of Silver et al. [72].
4.4.3 Gender Differences
We compared the reviews posted by males and females taking statin drugs. A large
portion of the reviews collected were labeled with gender, with 2,770 female and 2,156
male reviews. While it is possible that gender-specific word choice may influence the
term distributions, females clearly had more problems with neuromuscular disorders,
including muscle spasms. trouble walking and fibromyalqia. This is in line with ob-
Term ki k2  LLR p-value
inemory loss 318 11 166.2 5.1E-38
muscle pain 864 196 89.0 3.9E-21
depression 335 56 58.4 2.1E-14
muscle weakness 257 62 21.3 4.0E-06
als 38 1 21.0 4.7E-06
hair loss 126 26 14.9 1.1E-04
diabetes 133 31 11.9 5.6E-04
heart failure 24 1 11.6 6.7E-04
parkinson's disease 19 1 8.4 3.8E-03
chronic diarrhea 3 44 84.2 4.6E-20
gall bladder 16 44 46.3 9.9E-12
rash 127 121 36.1 1.8E-09
severe itching 14 35 34.5 4.3E-09
servations from the literature [34]. The prevalence of terms relating to libido among
males is possibly due to the fact that statins interfere with testosterone synthesis from
cholesterol [79]. Selected terms are shown in Table 4.5.
Table 4.5: Selected words and phrases in the statin reviews that distributed differently
over gender. ki: male reviews. k2: female reviews.
4.4.4 Lipophilic vs Hydrophilic Statins
For this comparison. we were most interested in the supposition that lipophilic statins
may have a greater impact on the nervous system, particularly on oligodendrocytes.
as discussed in Section 4.1. We consider statins with a positive lipophilicity to be
lipophilic, and negative lipophilicity to be hydrophilic. Of the widely prescribed
statins, atorvastatin (Lipitor) and sinivastatin are both lipophilic. while rosuvastatin
is hydrophilic [89]. Results were striking in that the severe neurological disorders.
ALS and Parkinsoi's, occurred almost exclusively in comments associated with the
lipophilic class. Selected terms can be found in Table 4.6.
4.5 Discussion
The results of these experiments show that corpus comparison methods can identify
side effects and areas of concern that are more associated with one class of drugs
Term ki k2 LLR p-value
sex drive 50 16 28.3 1.0E-07
libido 38 15 17.1 3.6E-05
soreness 69 44 13.9 1.9E-04
fibromyalgia 6 42 22.3 2.3E-06
cramps 139 264 15.7 7.6E-05
muscle spasms 11 38 9.8 1.7E-03
trouble walking 0 11 9.7 1.9E-03
arthritis 46 94 7.2 7.5E-03
Table 4.6: Selected words that were more common in lipophilic than in hydrophilic
statin reviews. ki: lipophilic statin reviews. k2 : hydrophilic statin reviews.
than another. One initial concern was that it may be difficult to distinguish between
patient preconditions and side effects using a bag-of-words approach. For example.
a patient might state "I took Lipitor because I had high cholesterol but it caused
muscle aches ~ However, by comparing drug classes used for the same purpose (e.g.
of lowering cholesterol), we control for preconditions which should distribute evenly
across both classes.
The highly ranked terms are those that not only appear frequently in one class,
but also are more skewed to one class than another. A patient who takes statins, for
example, is more likely to experience muscle pain than a patient who takes another
cholesterol-lowering drug., such as niaspan, because the class preference of the term
muscle pain is skewed toward statins. However, a patient taking statins is not neces-
sarily more likely to experience mermo'ry loss than muscle pain, even though 'Iiemory
loss appears higher on the ranked list of terms that prefer statin drug reviews. What
this means instead is that the skew in the two data sets on memory loss is greater
than it is on muscle pain.
4.5.1 Limitations
While our study used only term and drug class co-occurrence, we believe further im-
provements can be made to side effect detection using parsing. For example, consider
the term heart failure. In the context below, it is part of a general statement someone
is making., based not on personal experience, but hearsay:
...statins are costly, marginally effective, and rife with adverse effects.
Term k1 k2  LLR p-value
tingling 278 47 14.61 1.32E-04
tremors 38 1 13.32 2.63E-04
parkinson's 29 0 13.01 3.10E-04
als 35 3 5.98 1.44E-02
neurological 16 0 6.55 1.05E-02
Common side effects of statin drugs include muscle pain and weakness
and liver problems. However, they are also linked with memory problems.
heart failure, and increased risk of death...
This comment suggests potential side effects that the user did not personally experi-
ence. Whether the number of such comments significantly inflates the saliency of side
effects should be further investigated. Even when a term does appear in the context
of personal experience, it may be an existing precondition:
I am a 58 vear old male diagnosed with heart failure and afib in Jan 2004.
I have been taking a combination of Lipitor, Topral, Hyzaar, Pacerone
and Magnesium and Potassium supplements since then...
We want to distinguish between existing preconditions and cases of interest where the
term is mentioned as a clear consequence of taking the drug, such as in the following
comment:
I haved been on Lipitor for a niunber of years with many of the side effects
posted here. I have had Heart Failure fo a year now ... i am off lipitor an
taking 400mg of coq10 per clay. i am now in day seven an have slept in
my own bed with my wife for the first time in a year. i am less restless.
an have ha no recurrence of heart failure.
4.6 Summary
In this chapter, we have described a basic strategy of comparing word frequency distri-
butions between two databases with highly similar topics - e.g.. statin and non-statin
cholesterol lowering therapies - as a means to uncover statistically salient phrase pat-
terns. Our efforts focused on statin drugs, as these are a widely prescribed medication
with diverse side effects. We uncovered a statistically significant association of statin
drugs with a broad spectrum of health issues, including memory problems, neurolog-
ical conditions, mood disorders, arthritis and diabetes. in addition to very common
complaints of muscle pain and weakness. Many of our findings are supported by the
research literature on statins.
These experiments were inspired by the study conducted by Jeff Cable [8]. While
he looked at only 350 reviews, he used careful manual analysis to deduce associated
side effects. We looked at a much larger set of reviews (over 12,000). and used
statistical NLP techniques for analysis. On the one hand, it is gratifying that both
methods uncovered similar side-effect profiles on different data. On the other hand,
it is disturbing that a drug class as widely prescribed as the statin drugs has such
severe and sometimes life-threatening adverse reactions.
Chapter 5
Speech Recognition Experiments
As part of the drug reports system, users will have the ability to interact using natu-
ral language. making the systen more engaging by better emulating interactions with
human experts. We would like to allow the system to support queries beyond simple
key word searching. Part of the challenge of applying speech recognition and lan-
guage modeling techniques in the medical domain is the limited coverage that general
lexica have for specialized words and pronunciations. General language and lexical
models need to be updated to include drug and disease names, and their pronuncia-
tions. Recognition must also be robust to mispronunciations when users often do not
know the right pronunciation. even when it is available. In this chapter, we present
the results of preliminary experiments conducted to develop a language niodel for
recognizing questions a user might ask relating to medical drugs and symptoms.
5.1 Collection of Spoken Questions Data
We collected spoken utterances relevant to the domain with Amazon Mechanical
Turk' (AMT). AMT is a crowdsourcing tool has been used extensively by researchers
to collect large amounts of data in a quick and cost-efficient manner, especially for
natural language processing tasks. For example, it has been used to evaluate trans-
lation quality [9], annotate data [78], and transcribe spoken language [51].
1
www.mturk.com
We collected the data in two stages. First, a task was created in which workers
were asked to read an anecdote about a statin drug experience, and then come up
with questions that the anecdote might answer. The anecdotes were drawn from
snippets of conunents collected online. An example prompt is shown in Figure 5-1.
and sample anecdotes can be found in Appendix B.
Ask 2 questions about cholesterol related drug experiences
Imagine that there exists a large set of patient-reported anecdotes about medical drug
experiences, specifically relating to cholesterol-lowering drugs (statins). Imagine also
that a service is available that allows you to ask questions related to drug experiences
and will provide you with a set of relevant anecdotes to browse.
Your task is to:
1. Read the following anecdote about a statin drug (or statin drugs).
2. Come up with two questions about the drug that might be answered by the
anecdote.
Please remember:
" The questions must use standard English and spelling.
* The questions must relate to statin drugs or cholesterol-related health problems.
" Try to phrase the questions in a variety of different ways.
Figure 5-1: Prompt presented to Amazon Mechanical Turk workers to collect sample
questions about cholesterol-lowering drug experiences.
In the second stage, speech data were collected from native speakers of American
English by asking another group of turkers to read the questions posed earlier. The
use of Amazon Mechanical Turk was a cost-effective way to collect speech data. Of
the over 4500 utterances collected, only 40 were unusable due to recording noise or
non-native pronunciation. Sample questions can be found in Appendix C.1.
In addition, turkers were asked to imagine that they were taking a new drug, and
to cone up with questions they would ask to a group of people who had experience
taking that drug. From this task, we collected a set of less constrained questions in
text format. Sample questions can be found in Appendix C.2.
From the AMT tasks. a total of 935 spoken questions relating to statins were
collected. An additional 318 general drug-related questions were collected in text
format only. Speech data were collected only for the statin questions because the
speech recognition tasks were primarily focused on statins and cholesterol.
5.2 Methods
To perform the speech recognition, we used the SUMMIT speech recognizer developed
in our group [95]. The SUMMIT recognizer works by composing a series of finite state
transducers modeling the acoustic information, the context dependent phones. the
pronunciation rules mapping phones to phonemes, the lexicon. and the grammar. In
adapting the models to the medical domain, we made changes mainly to the lexicon,
by adding pronunciations for words not found in the vocabulary, and developed a
domain-specific trigram language model.
5.2.1 Trigram Language Model
An n-gram language model predicts the most likely word given a history of n words.
This can be expressed as a probability:
P(wwiw_1, wi- 2 . . . . W-n) (5.1)
The maximum likelihood estimation of these probabilities is based on the observed
counts of these n-grams in the training corpus:
- count(win W i - 2, wi, i)
MwEV Count(win, ... , W2- Wi- 1 , W) (5 2 )
count(win, 
... , Wj 2 , Wim. w-i)
count(win, wi2- Wi- 1)
where V is the vocabulary, or the set of unique words that appear in the training
data. The language model used was based on trigrams, which is probably the most
dominant language model used today.
5.2.2 Data Sparsity
Given that this project concerns a new domain, we face issues with sparse data.
Maximum likelihood models often place too much emphasis on the training data
given, and do not generalize well to unseen word sequences.
Smoothing
Smoothing techniques help to alleviate the problem of data sparsity by redistributing
probability mass from observed n-grams to events that arc unobserved in the training
corpus. We used Knescr-Ney discounting. in which rare n-grams have probabilities
that back off to lower-order n-grams. In a trigram model, rare trigram probabilities
will back off to the probability of the bigramn, based on how many contexts the word
appears in.
Class N-gram Models
In addition to smoothing, we also used class n-grams to deal with the data sparsity
problem. Selected words were assigned to each class, and n-gram probabilities were
calculated using counts of class sequences. The class-based n-gram calculates word
probabilities as follows:
P(wij'wi_1,wi-2)(53
P(wilc(wi)) x P(c(wi)Ic(wi_1), c(wi-2))
where c(w) is the class that word w belongs to.
Using class n-grams allows us to easily incorporate semantic information into
models based heavily on statistics. Furthermore, this allows us to better predict
words that do not appear frequently in the training corpus, but that belong to the
same class as more frequent words.
The classes used in training the class n-gram models were manually created by
forming rules for words that were found to be significant in the corpus. Table 5.1 lists
the classes used and some representative word members.
Table 5.1: Classes used for class n-gram training.
Class J Words
statins lipitor, zocor, baycol,
sinivastatin, crestor,
vytorin, lovastatin,
tricor. pravachol
body parts shoulder. arm,
fingers. muscle, leg,
tendon. thigh
symptoms anxiety, numbness
pain, tingling,
soreness. fatigue.
ache. exhaustion
diseases parkinson's, polio,
alzheiner's
Supplementary Training Data
The high cost of acquiring speech data for this new domain was a limiting factor on
the amount of training data available for generating these language models. How-
ever, the language model training data does not need to come solely from the spoken
questions collected. We also used text data to train the language models, including
the comments that inspired the questions (665 utterances), the general drug ques-
tions (318 utterances), and the Michigan Corpus of Academic Spoken English (Mi-
CASE) transcripts (96246 utterances), a general spoken English corpus containing
transcripts from lectures, classroom discussions, and advising sessions, among other
general speech activities [751.
5.3 Results and Discussion
Five-fold cross validation was performed and the word error rate (WER) in both
the training and test sets were compared. The baseline recognizer simply trained a
trigram language model on 80% of the data and was tested on the remaining 20%,
achieving 44.84% WER. In table 5.2, we can see that using a class trigram model
improved the recognizer to a 44.04% WER.
Class n-gram WER (train) WER (test)
no 26.46 44.84
yes 26.96 44.04
Table 5.2: The use of class n-grams slightly improves recognizer performance.
Next, the performance of class trigran models trained only on the training data
was compared to language models trained with supplementary texts. Various com-
binations of supplementary texts were tested. For each supplementary text. I tested
allowing only sentences with in-vocabulary words. and allowing all words, including
those that were out of the vocabulary of the training questions (OOV words). Table
5.3 summarizes the findings.
Allow OOV Add. corpus WER (train) WER (test)
yes Drug comments 30.11 43.70
no Drug comments 26.98 43.90
yes Gen. questions 27.88 43.24
no Gen. questions 26.92 43.86
yes Gen. questions. 30.08 43.02
Drug conments
no Gen. questions. 26.94 43.84
Drug comments
yes Gen. questions. 49.64 59.42
Drug comments,
MiCASE
no Gen. questions. 28.98 46.66
Drug comments,
MiCASE
Table 5.3: Word error rate for various training sets. Additional corpora were used to
train the language model, including the comments about statins collected from online
forums (and were then used to prompt turkers to ask questions), general medicine-
related questions, and the MiCASE corpus.
The use of both additional drug-related questions and the comments which in-
spired the statin-related questions improved the performance of the recognizer. These
additional corpora both add to the types of sentence structure on which the language
model is trained. We may observe the same phrasing in general drug questions as
those posed specifically regarding statins. The statin-related questions of interest may
also have been phrased in a manner similar to the connents that the turkers first
read. With limited training data, these additional corpora help the language model
generalize and perform with anywhere from a 0.34% to 1.02% decrease in WER.
When the MiCASE corpus was added, we observed a dramatic drop in recognition
performance, because the language model is overwhelmed by irrelevant data. which
does not aid in predicting words for statin-related questions. Notice that the perfor-
mance improves when we limit the additional text to only in-vocabulary sentences in
the case of the MiCASE corpus. The opposite effect is seen with the drug comments
corpus and the general medicine questions corpora. Performance improvements in
the recognizer are only seen when the additional training corpora contain sentences
and sentence structure that relate to the recognition task.
Word error rates for the spoken question data were generally in the range of 40-
50% for test data using language imodels trained on a subset of the data. The best
performing training conditions used both a class n-gram and supplementary corpora of
both the online patient comments regarding statins and the general medical questions,
which resulted in nearly a 2% decrease in word error rates.
While the word error rates may seem high, the recognizer erred mostly on common
words, or plurality. The ability of the recognizer to identify important words - drug
names, symptoms - shows that it is still useful for our purposes of answering drug-
related questions. Some of these recognition problems can likely be overcome by using
a syntactic grannnar to give higher probabilities to granmmnatical sentences. which is
part of an on-going investigation.
5.4 Summary
We presented the preliminary experiments on recognition of spoken queries to the
system. Methods to improve speech recognition through improved language modeling
were explored. The use of class-based trigramns demonstrated an improvement over
regular trigrams. Training on supplementary corpora related to statins and general
drugs led to modest performance increases.
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Chapter 6
Additional Preliminary
Experiments
This chapter presents a series of additional experiments conducted with the DrugRe-
ports data. We begin with a comparison of term identification methods, then show
the results from classification of the cholesterol-lowering drug reviews, and finally
demonstrate the application of LDA to automatically cluster related terms.
6.1 Multi-word Term Identification
In this section. we present some common methods of term extraction and preliminary
results. Term extraction is a process of automatically identifying multi-word units
(MWUs), or a group of two or more words that form a meaningful phrase. It is a
useful preprocessing step for tasks such as information retrieval to return relevant
documents [59], natural language generation [77], and parsing [87]. In our research.
it is used for topic identification with LDA, feature generation for classification, and
parsing.
The methods shown below are easily applicable to any n-grams, however we only
present detailed information for bigrams.
Table 6.1: Bigrams ranked by frequency.
6.1.1 Term Frequency
The simplest method of finding multi-word terms is by finding terms that appear the
most frequently. Using this nethod. many uninteresting terms appear because they
contain connon words, as seen in Table 6.1. By simply filtering out stop words, we
can improve the candidate bigrams. as shown in Table 6.2.
Rank Bigran Count Rank Bigran Count
1 side effects 1736 11 go back 443
2 take care 1017 12 2 years 437
3 don't know 956 13 fish oil 419
4 years ago 946 14 coq 10 417
5 blood pressure 697 15 much better 412
6 heart attack 599 16 started taking 407
7 muscle pain 577 17 stopped taking 394
8 feel like 546 18 40 mug 380
9 year old 525 19 sounds like 379
10 side effect 486 20 every day 377
Table 6.2: Bigrains ranked by frequency with stop words renoved.
Rank Bigram Count Rank Bigram Count
1 i have 10455 11 to be 3352
2 i am 8629 12 on the 3189
3 i was 6612 13 have been 3093
4 in the 6025 14 that i 3041
5 of the 5254 15 for the 2966
6 i had 5070 16 when i 2956
7 and i 4687 17 have a 2894
8 to the 3899 18 it was 2865
9 it is 3827 19 but i 2714
10 in my 3442 20 have to 2637
6.1.2 Part of Speech Filter
Justeson and Katz [40] pass candidate terms through a part-of-speech filter to achieve
a huge improvement. They suggest patterns with examples. which we list briefly in
Table 6.3.
spectively.
The letters A, N, and P represent adjective, noun, and preposition, re-
Table 6.3: Example part of speech patterns for terminology extraction.
When we apply a manual part of speech filter to the stoplist filtered terms, we see
much better results. The top ranked bigrams can be seen in Table 6.4. Other than
temporal and measure terms. the top bigrams are all valid terms. The difficulty with
this method is that many unknown words may not be recognized by a part of speech
tagger.
Rank Bigram Count Rank Bigram Count
1 side effects 1736 11 blood sugar 366
2 blood pressure 697 12 20 mug 356
3 heart attack 599 13 10 mg 354
4 muscle pain 577 14 3 months 351
5 side effect 486 15 heart disease 344
6 2 years 437 16 acid reflux 337
7 fish oil 419 17 vitamin d 337
8 40 mg 380 18 6 months 335
9 every day 377 19 last night 324
10 high cholesterol 375 20 2 weeks 324
Table 6.4: Bigrams passed through a part of speech pattern filter.
Passing through a character filter, that only allows the letters a-z, achieves much
Pattern Example
AN linear function
NN regression coefficients
AAN Gaussian random variable
ANN cumulative distribution function
NAN mean squared error
NNN class probability function
NPN degrees of freedom
better results, as seen in Table 6.5
Rank Bigrain Count Rank Bigram Count
1 side effects 1736 11 vitamin d 337
2 blood pressure 697 12 acid reflux 337
3 heart attack 599 13 last night 324
4 muscle pain 577 14 statin drugs 317
5 side effect 486 15 long time 296
6 fish oil 419 16 chest pain 294
7 every day 377 17 first time 262
8 high cholesterol 375 18 many people 259
9 blood sugar 366 19 high blood 252
10 heart disease 344 20 blood work 244
Table 6.5: Bigramns passed through a part of speech pattern filter and containing only
letters a-z.
6.1.3 Association Measures
Purely statistical measures can be used to extract terns. Below., we define some
conunonly used association measures given a bigrai, [wI., w2].
Pointwise Mutual Information
Pointwise Mutual Information, defined in Equation 6.1. was first defined by Fano [22]
and has been used by Church and Hanks [11] to find word association norms and
Smadja et al. [76] to find collocations for translation purposes.
Highly ranked bigrams can be seen inl Table 6.6, where bolded terms are valid
multi-word units.
I(wi, W 2) log 2 P(W1 W2)p(wi)p(w2)
(6.1)
Symmetrical Conditional Probability
Silva [71] introduced the Symmetrical Conditional Probability (SCP) of bigrams,
which they showed to have the highest precision in detecting multi-word units when
Rank Bigrarn PMI Rank Bigram PMI
1 alpha lipoic 17.0 11 panic resources 12.6
2 carpal tunnel 14.8 12 ct scan 12.3
3 coenzyme q 13.7 13 million dollars 12.2
4 peripheral neuropathy 13.5 14 nurse practioner 12.2
5 stretching exercises 13.3 15 cell phone 12.2
6 horror stories 13.0 16 dark urine 12.0
7 tennis elbow 12.8 17 play tennis 11.9
8 greatly appreciated 12.7 18 cold turkey 11.7
9 contributing factor 12.6 19 sudden onset 11.6
10 law suit 12.6 20 medical profession 11.6
Table 6.6: Bigrais ranked by pointwise mutual information.
compared to other measures such as PMI, Dunning's log likelihood statistic, and the
Dice coefficient. The SCP measure is defined in Equation 6.2.
Highly ranked bigrams can be seen in Table 6.7. where bolded terms are valid
multi-word units.
SCP(wi, w 2) =
p(wI)p(w 2)
Rank Bigram PMI Rank Bigram PMI
1 carpal tunnel 9.1 11 acid reflux 1.7
2 side effects 6.0 12 q -10 1.6
3 alpha lipoic 5.3 13 heart attack 1.6
4 fish oil 4.8 14 panic resources 1.3
5 coenzyme q 2.8 15 side effect 1.1
6 blood pressure 2.7 16 greatly appreciated 1.1
7 peripheral neuropathy 2.6 17 years ago 1.1
8 coq 10 2.5 18 take care 11.1
9 ct scan 2.4 19 memory loss 1.0
10 vitamin d 1.8 20 year old 0.9
Table 6.7: Bigrans ranked by symnietric conditional probability.
(6.2)
6.1.4 Discussion
The results from the association measures (PMI and SCP) were quite similar, with
both identifying about 15 valid multi-word units in the top 20. Though the filter
method presented better results, it relies on a part of speech tagger. which may not be
accurate for the out-of-vocabulary words common in the medical domain. Depending
on the purpose of the MWU extraction task, different methods may be preferred.
These methods are also valuable to generate a high quality list of MWUs for manual
identification.
6.2 Side Effect Term Extraction
Related to the task of MWU identification is term extraction. We are especially
interested in identifying side effect terms. While previous medical NLP research often
relies on medical lexica such as those provided by UMLS or the FDA's COSTART
corpus, we chose not to use these restrictive lexica because they have low coverage of
colloquial side effect expressions.
We extracted side effects from the connnents posted to Askapatient.com, which
contains over 100,000 drug reviews, covering all drugs. and has labeled side effect
data. Patients are able to submit drug reviews with an input for "side effects" where
they could enter comments specifically related to side effects. Not all users used that
area; some users entered free text. However, many users entered comma separated
side effect terms, such as the comment below:
Body aches, joint pain, decreased mobility. decreased testosterone and
libido, difficulty getting out of bed in the morning, tingling and itchy
hands,and decrease in overall strength.
Side effects were selected using regular expression (regex) string matching heuris-
tics, including searching for comma-separated values. Qualifying terms such as slight.
overvwheirngIy and extremely were removed'. and plural terms were consolidated.
'The entire list can be found in AppendixD
Terms that appeared at least 20 times were included. For a rough idea of the dispar-
ity, of the nearly 5.600 adverse effect terms found in the COSTART corpus2 , only 176
are shared with the 1,057 side effect terms we identified fron the online drug reviews.
Some of the most common side effects are shown in Table 6.8. The terms in bold
are not found in the COSTART corpus., and most are valid side effect terms. As we
go further down the list, we see even less coverage of colloquial terns.
Rank Side Effect Count Rank Side Effect Count
1 weight gain 5762 21 irritability 1248
2 headache 5689 22 weight loss 1219
3 nausea 5621 23 drowsiness 1129
4 none 4713 24 night sweats 1055
5 fatigue 4628 25 memory loss 995
6 depression 4562 26 acne 984
7 insomnia 3750 27 sleepiness 962
8 dizziness 3691 28 vomiting 899
9 anxiety 3592 29 confusion 884
10 dry mouth 3006 30 blurred vision 865
11 mood swings 2660 31 feet 860
12 constipation 2024 32 no side effects 849
13 loss of appetite 1795 33 itching 840
14 tired 1698 34 moodiness 820
15 bloating 1592 35 vivid dreams 807
16 hair loss 1525 36 sweating 779
17 tiredness 1361 37 lethargy 749
18 joint pain 1348 38 dizzy 726
19 hot flashes 1341 39 stomach pain 713
20 diarrhea 1308 40 weakness 671
Table 6.8: Side effects extracted from the
found in the COSTART corpus of adverse
Askapatient corpus. Bolded
reaction terms.
terms are not
6.3 Review Classification
Unsupervised document classification is an important task previously applied to a
wide range of text such as technical abstracts, news stories. and spain e-mails. We
2 http://hedwig.mgh.harvard.edu/biostatistics/files/costart.html
perform the classification task on the cholesterol-lowering drug reviews, classifying re-
views as either a statin review or non-statin review. As each drug class has different
tendencies for specific side effects, we can train a document classification model to
classify an unlabeled drug review into a specific drug class using these terms as learn-
ing features. Our findings both validate the utility of the side effects for identifying
the drug class and offer a useful technique for automatic assignment of unlabeled re-
views. These experiments were conducted jointly with JingJing Liu, a fellow graduate
student.
6.3.1 Methods
We use a Support Vector Machine [39] classifier to classify comments based on the
drug class. We compared 7,971 reviews on statin drugs with 3,549 reviews on non-
statin drugs using ten-fold cross validation. As a baseline, we use a classification
model trained on all the unigramns in the drug reviews. We compare this with a
system that uses as features the words and phrases that are skewed in distribution
between the two datasets, according to the log likelihood statistic. Given the list
of terms ranked by log likelihood, we filtered out terms with p-value higher than
0.05 (equivalently, log likelihood lower than 3.85). 1,991 terms selected using this
threshold cutoff were used to train the LLR classification model.
Obviously,. the drug's name is a very strong indicator of the drug class, but has no
information about side effects (e.g.. a review containing the term lipitor is most likely
to be a review related to statin drugs). Therefore, we conducted a second experiment
where all drug names were removed from both the unigrams used in the baseline
system and the terms used in the LLR system.
6.3.2 Results
Table 6.9 presents the experimental results on classification. BS represents the base-
line system using all the unigrams in the reviews for model training. LLR represents
our classification model trained on the 1.,991 terms selected by the log likelihood
Table 6.9: Drug review classification performance. BS: baseline; LLR: log likelihood
ratio: DN: drug names. Precision, recall. and F-score are for statin reviews.
method. BS - DN represents the baseline trained on unigrans without drug names.
LLR - DN represents the LLR system trained on 1,959 terms learned by the log
likelihood method with drug names removed. Experimental results show that the
LLR system outperforms the baseline system in both settings (with or without drug
naimes).
6.3.3 Discussion
As expected, without the drug name features, performance drops in both systems.
However, even without drug names, the LLR system can still achieve over 80% preci-
sion on the classification task. This indicates that the drug classes can be predicted
quite well based on their unique side effect profile, by exploiting the LLR-derived
features.
The classification experiments presented can serve as a good starting point for
identifying unlabeled patient reviews. While our experiments were conducted on la-
beled data from drug review sites. many patient comments on health forums also
contain personal anecdotes about medical drugs. We can use those comments to sup-
plement the drug reviews for a larger data set. For this application., the classification
threshold should be adjusted to achieve higher precision.
6.4 Topic Modeling
Topic models are also a useful tool for processing large collections of documents by
more efficiently representing text, and aid in discovering abstract concepts in text.
Feature Set Accuracy Precision Recall F-score
BS 84.4% 82.9% 97.8% 89.7
LLR. 87.1% 86.3% 96.8% 91.2
BS - DN 78.4% 76.8% 98.6% 86.3
LLR - DN 80.1% 80.6% 95.6% 87.4
Methods in Latent Semantic Analysis (LSA) and LDA, which is a generalization of
probabilistic LSA developed by Blei et al. [7]. and currently one of the most used topic
models, represents documents as a random mixture of topics, or word distributions.
LDA has been employed in the biomedical domain to characterize the change in
research focus over time in a bioinformatics journal [90]. We applied LDA to the
corpus of cholesterol-lowering drug reviews to discover correlated terms.
6.4.1 Methods
We used the MALLET toolkits to perform topic classification with LDA on the entire
corpus. Because MALLET processes only unigrams, we preprocessed the raw text
data by joining (via the device of underbars) common multi-word side effect terms.
found as described in Section 6.2. as we are most interested in side effect classes.
6.4.2 Results and Discussion
A total of 100 latent topics were generated using LDA. While some of the automati-
cally generated topics appeared somewhat arbitrary. several topics could be assigned
a clear label associated with a side effect class, as illustrated in Table 6.10. Perhaps
the most striking topic is one we have labeled as "-neurological," which included lipitor
(a lipophilic statin) in a class with parkinson. neuroiogist, twitching and tremors.
LDA generated many useful classes of side effects. These can be used to as fea-
tures to improve classification [6]. or associated with ratable aspects to generate text
summaries [801.
3http://mallet.cs.umass.edu/
Topic Terms
muscle aches pain. left, arm, shoulder, neck, elbow, upper, shoulder, pain, hand,
developed. neck pain, lift, sore, feels, blade, npper back, hurts, blades,
arm pain
weakness muscle pain, weakness, fatigue, extreme, general, muscle weakness,
stiffness. symptoms.tiredness, joint, severe. malaise, muscle fatigue.
difficulty walking. cq, extremities, dark urine, clear, stronger
mental fatigue, depression. extreme, anxiety. insomnia, memory loss, weight
problems gain, energy, mild, tiredness, short term memory loss, shortness of
breath, exhaustion, muscle aches, night sweats, lethargy, mental,
experiencing, confusion
neurological lipitor, husband, diagnosed, recently., suffered, yrs, disease., parkinson's.
disorders early, connection, mentioned, neurologist, diagnosis, result, tremors, prior,
suggest, possibility, twitching
indigestion stomach. gas, terrible. constipation, bloating., chest, back., chest pain,
abdominal pain, back pain, stomach pain, heartburn, acid reflux, bad.
chest pains, rib, sick, abdomen, indigestion
arthritis knees, joint pain, arthritis, joints, hand, pain. joint, hands, fingers. hips,
shoulders, stiff, painful, finger, elbows
skin problems itching, rash, skin, itchy. itch, reaction, burning, hot flashes, red, hives,
hot, relief, redness. cream, broke, allergic. area, benadryl, unbearable
Table 6.10: Examples of latent classes automatically discovered using LDA
74
Chapter 7
Conclusions and Future Work
In this work, we have presented a new corpus of online patient-provided drug reviews
and described preliminary experiments in developing a speech-enabled online interface
for patients who want to learn more about side effects and experiences with pharmna-
ceutical drugs. Using statistical methods., we denmonstrate that patient-provided text
can be used both to confirm known side effects and to discover new side effects of
cholesterol-lowering drugs. They are also useful for extracting and grouping colloquial
side effect terms.
In our study of cholesterol-lowering drugs, we used several popular statistical NLP
techniques to detect biases in word distributions when comparing reviews of statin
drugs with reviews of other cholesterol-lowering drugs. We found a statistically sig-
nificant association between statins and a wide range of disorders and conditions.
including diabetes. depression, Parkinson's disease, memory loss, Lou Gehrig's dis-
case, fibromnyalgia and heart failure. A review of the research literature on statin side
effects also corroborates our findings. These results show promise for patient drug
reviews to serve as a data source for pharmacovigilance.
We also collected spoken data of questions regarding medical drugs and associ-
ated symptoms with transcriptions. Methods to improve speech recognition in the
medical domain through language modeling were explored, and we obtained slight
improvements using class-based trigrams and supplementary text training data.
Finally, we used statistical measures and simple string matching to extract col-
loquial side effect terms from the drug reviews. We found that many concepts are
represented differently in patient vocabulary and medical lexica.
In the future. we plan to expand our methods to other drug classes, such as psycho-
pharmaceuticals and acid reflux therapies. We also encountered many terms in our
analysis that were biased toward one data set, but were not statistically significant.
The data sparsity issue can be addressed by collecting more drug experience com-
ments. Classification methods may also be used to identify unlabeled patient reviews
to supplement the labeled connents. Future work will address some of the issues
we encountered by better filtering comments for only personal experiences. Syntactic
parsers can also be applied to demonstrate a clearer cause and effect relation between
drugs and adverse reactions.
Ultimately, the results of these experiments will be used to help consumers decide
which medicines to take, if any.
Appendix A
Hierarchy for Cholesterol Lowering
Drugs
N statin
- atorvastatin: lipitor, torvast
- cerivastatin: baycol, lipobay
- fluvastatin: lescol, lescol xl, canef, vastin
- lovastatin: altocor, altoprev, mevacor
- pravastatin: pravachol., sclcktine, lipostat
- pitavastatill: livalo, pitava
- rosuvastatin: crestor
- simvastatin: zocor, lipex, ranzolont, sinivador, velastatin
m statin combination
- atorvastatin/amlodipine: caduet, envacar
ezetimibe/sinivastatin: vytorin
- niacin/lovastatin: advicor
- niacin/simvastatin: simcor
- pravastatin/fenofibrate
P bile acid sequestrant
- cholestyra mine: questran, questran light, prevalite
- colesevelam: cholestagel, welchol
- colestilan
- colestipol: colestid
- colextran: dexide
fibrate
- aluminium clofibrate
- bezafibrate: bezalip
- ciprofibrate: nodalim. oroxadin
- clinofibrate
- clofibrate: atromid-s, atromid
- clofibride
- etofibrate: clofibrate/niacin
- fenofibrate: tricor. trilipix. fenoglide, lipofen, lofibra, antara, fibricor, triglide
- genifibrozil: lopid, genicor
- ronifibrate
- sinfibrate
m niacin derivatives
- niacil: iicotilic acid
* slo-niacin
* niaspan: niaspan er
- acipimox: olbetam
- nicotinamide: niacinamide, nicotinic acid amide
P cholesterol absorption inhibitor
- ezetimibe: zetia, ezetrol
Appendix B
Anecdotes for AMT Question
Collection
Below are sample anecdotes presented to workers on Amazon Mechanical Turk to
collect questions that patients might ask that could be answered by these coin-
inents. These anecdotes were drawn from original patient-reported cornnents posted
to health discussion websites.
o My doctor reconnended CoEnzyme Q10 after I complained about muscle pain
from Simvastatin. CoEnzyme Qi works treniendously. I started with the
lowest dosage, 50mg. once per day and I haven't needed to raise the dosage.
The pain was gone. Recently I needed to go off all vitamins, supplements for
a medical test. Within 2 days of being off CoEnzyne 10, the pain returned.
Looking forward to taking it again after the test.
P I am on a 80mg regimen of lipitor. I am experiencing severe leg cramps and my
legs have lost all muscle tone and are turning into sticks. Does this sound like
it is lipitor related? My doctor mentioned a CK test would this definitely show
something if it is?
P I have been diagnosed with severe arthritis for over ten years and told I need a
hip replacement. I knew until then I'd just have to tolerate the groin/thigh pain.
Well I started taking Lipitor and after about 6 months, I was in unbearable pain,
particularly both my thighs and buttocks and groin area. My doc took me off
the Lipito and in two weeks. my pain was lessened 50% or more - the right side
not helped so much as that is where the "bad hip is".
Started taking sinivastatin 40 mng and within 2 wks pain started in my neck and
thighs. The pain has gotten worse in my thighs, so I am going to stop med.
and see what happens. I have been this med. for 3 months.
My aunt is 82 years old, has had heart valve surgery a few years ago and is on
Zocor. she is currently hospitalized with severe pain in the upper back area.
Nothing seems to helo and oain killers make her hallucinate. Does anyone think
this pain could be Zocor related?
My husband started on Lovastatin in 2006. He started to notice weakness in his
right arm. This weakness progressed to the point that lie saw his MD in June
2007 thinking lie had a pinched nerve. After a couple of MRF's which did not
show a pinched nerve, lie was referrcd to a neurologist who gave him a diagnosis
of "possible ALS". In August 2007 on his 60th birthday, a second opinion
confirmed the diagnosis of ALS. Since that time, my husband has progressed
from weakness in his right arm to complete loss of function in his arms, very
weak leg muscles and difficulty breathing. The doctors are now encouraging us
to enter him into hospice care.
p I have been on 40mg Siivistatin for 3 years. The only problems have been
muscle twinges in one shoulder that has failed to heal over time as most, muscle
twinges do. In fact, the source of pain seems to be growing or spreading, which
is worrying.
P I have been experiencing a considerable amount of pain in my legs and feet as
mentioned in previous posts by other people. I am on Lipitor and all of the
tendons in my arms and legs seem to be inflamed. All of this cane upon me
slowly after starting Lipitor. I was once on Celebrex but discontinued use due
to stomach bleeding episodes. I now take Mobic. I am now under the care of a
"Pain Management" group.
Appendix C
Sample Questions Collected Using
AMT
C.l Cholesterol Lowering Drugs
m Are leg cramps a normal side effect of Lipitor?
N Could Lipitor be causing the numbness in my feet'?
> Does Vytorin cause exhaustion?
A How long does it take to get your strength back after stopping statins?
o If I start taking Lipitor and have side effects. are there other drugs I can take?
o Is there any association between statin drug use and kidney problens?
* What are the long term effects of Lipitor?
> What other drugs can I try if I don't like Zocor?
> Will discontinuing Zocor alleviate the muscle pain?
C.2 General Medication
P How soon can I drive after taking my Ambien?
p If I have to skip a dose of Nexiuni, how quickly will my acid reflux return?
P Will Yasmin hurt the baby if I get pregnant?
o Will taking this medication affect the use of other ieds I am taking?
If I take prednisone for more than 2 weeks, can I stop it suddenly?
o Can Nexium cause diarrhea?
What are the differences between Lexapro and Celexa?
Are there particular drugs to avoid while on Rainipril?
i If I have bad kidneys, can I take Advil?
Appendix D
Qualifying Terms Excluded from
Side Effects
almost intermittent serious
always maj or severe
complete massive slight,
constant mild slightly
extreme minor some
extremely occasional still
general overall terrible
horrible overwhelming very
intense possible
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